OBESITY OR OVERWEIGHT
Clinical trials for OBESITY OR OVERWEIGHT explained in plain language.
Never miss a new study
Get alerted when new OBESITY OR OVERWEIGHT trials appear
Sign up with your email to follow new studies for OBESITY OR OVERWEIGHT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New daily pill shows promise for weight loss in obesity trial
Disease control CompletedThis study tested an experimental oral tablet called AZD5004, taken once daily for 36 weeks, to see if it helps people with obesity or overweight lose weight. About 310 adults aged 18 and older with a body mass index of 27 or higher and at least one weight-related health problem …
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 10:40 UTC
-
New combo shot helps east asians shed pounds in major trial
Disease control CompletedThis study tested a new weekly injection called CagriSema (a mix of two medicines) in 331 East Asian adults with overweight or obesity. Participants received the shot for about 1.5 years to see how much weight they lost compared to those taking semaglutide alone. The goal was to …
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 17, 2026 10:39 UTC
-
New combo shot CagriSema shows promise for weight loss in chinese study
Disease control CompletedThis study tested a new weekly injection called CagriSema (a mix of two medicines) to help Chinese adults with obesity or overweight lose weight. About 300 participants received either CagriSema, a dummy shot, or semaglutide alone for about a year. The main goal was to see how mu…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 17, 2026 10:38 UTC
-
New weight-loss drug AZD5004 tested in chinese adults
Disease control CompletedThis early-stage study tested the safety and tolerability of a new drug called AZD5004 in 45 Chinese adults who were overweight or obese, with or without type 2 diabetes. Participants received either the drug or a placebo, and researchers monitored side effects and how the drug m…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE1 • Sponsor: Eccogene • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New weekly shot shows promise for shedding pounds in obesity trial
Disease control CompletedThis study tested a new medicine called AZD6234, given as a weekly shot, to help people with obesity or overweight lose weight. 262 adults took part, receiving either the drug or a placebo for 36 weeks. The main goal was to see if the drug led to greater weight loss than placebo,…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 14, 2026 12:05 UTC